Salem Health

Salem Health was paid $65.77M by Medicaid between Jan 2018 and Dec 2024, across 302 billing codes. Its largest line is 99284, emergency room visit (serious) — 25% of everything it billed.

33Billing provider infoSALEM HEALTH
SALEM, OR 97301

33aNPI1265431829assigned 07/18/2005

33bProvider typeClinical Medical Laboratory

28Total paid$65.77M

24GClaims1,458,232

24DCodes billed302

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Clinical Medical Laboratory providers in Oregon

Rank by total paid#2 of 46

Median peer was paid$50K

This provider vs. median1,318×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	155,010	$4.96M
2019	167,828	$4.78M
2020	154,428	$5.16M
2021	242,499	$8.31M
2022	231,547	$8.38M
2023	267,279	$16.95M
2024incomplete	239,641	$17.22M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	25%	103,474	94,333	$16.27M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	21%	100,598	92,805	$13.50M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	6.9%	78,445	71,047	$4.54M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	6.0%	16,999	15,246	$3.93M
80053	Comprehensive metabolic panel	5.4%	146,542	129,960	$3.54M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	5.2%	50,376	46,058	$3.39M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	4.5%	58,449	53,626	$2.98M
99232	Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity	2.8%	46,574	17,674	$1.81M
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	2.0%	13,617	12,780	$1.31M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	1.9%	12,501	11,311	$1.27M
J0585	Injection, onabotulinumtoxina, 1 unit	1.8%	2,791	1,417	$1.15M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.6%	28,515	26,906	$1.08M

290 more codes

71046	Radiologic examination, chest; 2 views	1.5%	32,861	$1.01M
99223	Prolong inpt eval add15 m	1.2%	6,825	$793K
96375	Therapeutic injection; each additional sequential IV push	1.1%	28,072	$691K
99204	Doctor's office visit, new patient (more involved)	<1%	5,204	$614K
99239	Hospital discharge day management, more than 30 minutes	<1%	7,810	$556K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	9,089	$481K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	843	$384K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	4,079	$368K
95811		<1%	1,088	$366K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	1,609	$309K
0002A		<1%	12,826	$292K
0001A		<1%	14,026	$291K
64615		<1%	1,951	$261K
87631		<1%	12,119	$247K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	4,929	$246K
G0399	Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation	<1%	1,988	$183K
99215	Doctor's office visit, returning patient (complex)	<1%	2,226	$176K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	4,349	$166K
97803		<1%	3,532	$148K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	5,939	$136K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	153,733	$135K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	911	$133K
93970		<1%	5,128	$132K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	5,310	$120K
01967	Neuraxial labor analgesia/anesthesia for planned vaginal delivery	<1%	129	$119K
99222	Initial hospital care, per day, moderate complexity	<1%	1,300	$115K
36415	Collection of venous blood by venipuncture	<1%	80,414	$105K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	4,934	$99K
99238	Hospital discharge day management, 30 minutes or less	<1%	1,941	$87K
99460		<1%	896	$85K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	19,198	$81K
93971		<1%	5,573	$78K
70450	Computed tomography, head or brain; without contrast material	<1%	2,795	$73K
95910		<1%	456	$73K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,478	$73K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	698	$70K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	961	$64K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	103	$59K
81001		<1%	60,480	$59K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	879	$56K
95819		<1%	647	$51K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	847	$51K
95886		<1%	1,409	$38K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,483	$37K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,483	$37K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	335	$37K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	309	$37K
90834	Psychotherapy session, about 45 minutes	<1%	524	$36K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	1,044	$35K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	295	$34K
59025	Fetal non-stress test	<1%	699	$32K
80061	Lipid panel	<1%	3,765	$31K
87086	Culture, bacterial; quantitative colony count, urine	<1%	12,175	$31K
99464		<1%	441	$31K
99479	Subsequent intensive care, per day, very low birth weight infant	<1%	256	$30K
90686		<1%	1,403	$26K
84443	Thyroid stimulating hormone (TSH)	<1%	2,552	$25K
86780		<1%	2,490	$25K
90791	Psychiatric diagnostic evaluation	<1%	217	$25K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	72	$23K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	632	$23K
86140		<1%	7,532	$22K
99480	Subsequent intensive care, per day, low birth weight infant	<1%	200	$22K
83036	Hemoglobin; glycosylated (A1C)	<1%	3,555	$22K
87536		<1%	419	$22K
99219		<1%	293	$21K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,076	$19K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	1,647	$18K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	1,263	$16K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	852	$16K
0012A		<1%	671	$16K
73630		<1%	519	$16K
76813		<1%	146	$15K
71045	Radiologic examination, chest; single view	<1%	279	$15K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	336	$15K
86900		<1%	190	$14K
99469	Subsequent inpatient neonatal critical care, per day, 28 days or younger	<1%	46	$14K
0011A		<1%	706	$13K
87660		<1%	900	$13K
87510		<1%	900	$13K
87480		<1%	900	$13K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	94	$12K
85652		<1%	7,354	$11K
49083		<1%	14	$11K
83970		<1%	535	$11K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	60,606	$11K
99205	Prolong outpt/office vis	<1%	85	$10K
0004A		<1%	402	$10K
73610		<1%	284	$10K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	114	$10K
93000		<1%	913	$10K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	808	$9K
93922		<1%	1,030	$8K
84425		<1%	578	$8K
86803		<1%	677	$8K
99220		<1%	79	$8K
82607		<1%	797	$8K
82746		<1%	782	$7K
73110		<1%	221	$7K
99462		<1%	170	$7K
87070		<1%	1,194	$7K
86480		<1%	135	$7K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	56	$6K
99442		<1%	581	$6K
82550		<1%	7,941	$6K
20611		<1%	96	$5K
77014		<1%	140	$5K
87634		<1%	127	$5K
95908		<1%	42	$5K
J7030	Infusion, normal saline solution , 1000 cc	<1%	40,868	$5K
0031A		<1%	188	$5K
0064A		<1%	174	$5K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	27	$5K
86359		<1%	208	$5K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	372	$5K
84466		<1%	555	$5K
99459		<1%	279	$4K
82728		<1%	495	$4K
81003		<1%	2,881	$4K
76820		<1%	94	$4K
0071A		<1%	110	$4K
96361	Intravenous infusion, hydration; each additional hour	<1%	128	$4K
96160		<1%	1,173	$4K
90670		<1%	185	$4K
90656		<1%	174	$4K
G0444	Annual depression screening, 5 to 15 minutes	<1%	254	$4K
59514		<1%	12	$3K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	26	$3K
86361		<1%	191	$3K
73600		<1%	127	$3K
83880		<1%	161	$3K
80048	Basic metabolic panel (calcium, ionized)	<1%	697	$3K
90698		<1%	155	$3K
80069		<1%	871	$3K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	12	$3K
84703		<1%	6,297	$3K
99443		<1%	129	$3K
0240U		<1%	28	$3K
0072A		<1%	74	$3K
84481		<1%	284	$3K
83690		<1%	14,302	$3K
77336		<1%	25	$3K
99217		<1%	64	$3K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	211	$3K
84484		<1%	18,513	$2K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	14	$2K
90682		<1%	45	$2K
84439		<1%	445	$2K
83540		<1%	555	$2K
93880		<1%	70	$2K
94760		<1%	1,196	$2K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	26	$2K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	13	$2K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	13	$2K
82570		<1%	692	$2K
99221		<1%	21	$2K
87653		<1%	65	$2K
90677		<1%	83	$2K
90648		<1%	79	$2K
99173		<1%	519	$1K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	15	$1K
86360		<1%	46	$1K
96161		<1%	474	$1K
84702		<1%	380	$1K
87522	Neg quan hep c or qual rna	<1%	59	$1K
99463		<1%	12	$1K
93990		<1%	76	$1K
98968		<1%	33	$1K
97165		<1%	14	$1K
90723		<1%	54	$1K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	13	$1K
87340		<1%	254	$1K
80202		<1%	112	$1K
90715		<1%	47	$1K
87077		<1%	174	$919.76
73130		<1%	29	$917.47
84156		<1%	529	$891.51
83718		<1%	147	$868.03
99356		<1%	43	$848.63
96127		<1%	123	$789.29
85027		<1%	245	$776.19
99225		<1%	18	$751.47
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	26	$727.96
86317		<1%	65	$618.47
84478		<1%	147	$613.55
83605		<1%	4,285	$594.32
87186		<1%	83	$588.98
0124A		<1%	29	$581.24
20610		<1%	15	$560.01
90744		<1%	27	$548.92
87081		<1%	166	$544.70
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	150	$514.29
94060		<1%	88	$504.54
11045		<1%	33	$500.72
84630		<1%	70	$497.87
86787		<1%	58	$470.46
85014		<1%	341	$460.52
85610		<1%	1,259	$437.52
86704		<1%	50	$435.01
84590		<1%	57	$429.81
99406		<1%	40	$417.35
0054A		<1%	14	$414.40
0003A		<1%	30	$408.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	43	$399.30
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	169	$388.90
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	4,615	$388.77
99417	Prolong home eval add 15m	<1%	12	$372.60
86694		<1%	18	$371.67
86850		<1%	255	$365.17
81025		<1%	65	$355.22
93244		<1%	18	$354.26
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	14	$354.14
93018		<1%	27	$350.38
82784		<1%	53	$320.08
90633		<1%	14	$292.04
0134A		<1%	14	$257.60
99441		<1%	26	$252.96
90713		<1%	15	$244.16
86364		<1%	26	$213.05
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	27	$186.62
84460		<1%	64	$186.38
90710		<1%	14	$185.32
84450		<1%	64	$182.07
83993		<1%	13	$176.50
82043		<1%	49	$166.57
83516		<1%	24	$165.43
82951		<1%	15	$165.31
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	95	$161.05
95874		<1%	59	$157.81
86334		<1%	17	$147.86
82947		<1%	40	$146.17
85730		<1%	85	$145.33
82248		<1%	30	$144.80
87205		<1%	40	$142.51
85018		<1%	153	$133.42
84163		<1%	13	$123.70
83883		<1%	28	$120.46
83655		<1%	12	$113.20
86762		<1%	117	$112.67
92552		<1%	33	$107.44
96150		<1%	13	$104.40
87071		<1%	31	$103.32
84550		<1%	62	$95.86
82553		<1%	6,242	$94.98
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	13,027	$90.08
83735		<1%	1,353	$70.67
84165		<1%	15	$55.39
82950		<1%	12	$53.89
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	6,904	$51.84
86592		<1%	12	$42.40
84160		<1%	15	$26.71
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	149	$22.55
82803		<1%	433	$18.00
86901		<1%	178	$10.32
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	84	$5.03
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	13	$1.69
J7120	Ringers lactate infusion, up to 1000 cc	<1%	3,498	$0.89
85379		0%	12	$0.00
J1170	Injection, hydromorphone, up to 4 mg	0%	529	$0.00
G0378	Hospital observation service, per hour	0%	376	$0.00
A9585	Injection, gadobutrol, 0.1 ml	0%	17	$0.00
J3490	Unclassified drugs	0%	271	$0.00
J2704	Injection, propofol, 10 mg	0%	1,669	$0.00
84075		0%	26	$0.00
96376		0%	84	$0.00
J3010	Injection, fentanyl citrate, 0.1 mg	0%	916	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	69	$0.00
J0696	Injection, ceftriaxone sodium, per 250 mg	0%	12	$0.00
99140		0%	13	$0.00
86376		0%	13	$0.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	44	$0.00
82040		0%	14	$0.00
J2250	Injection, midazolam hydrochloride, per 1 mg	0%	50	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	12	$0.00
J2060	Injection, lorazepam, 2 mg	0%	13	$0.00
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	0%	15	$0.00
C1769	Guide wire	0%	12	$0.00
84145		0%	586	$0.00
J2270	Injection, morphine sulfate, up to 10 mg	0%	1,584	$0.00
99152		0%	13	$0.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	0%	176	$0.00
87400		0%	42	$0.00
J2550	Injection, promethazine hcl, up to 50 mg	0%	16	$0.00
J1200	Injection, diphenhydramine hcl, up to 50 mg	0%	69	$0.00
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	0%	34	$0.00
84155		0%	26	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	14	$0.00
82247		0%	26	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	14	$0.00
C9113	Injection, pantoprazole sodium, per vial	0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNESTER WOLFE, CHERYL (PRESIDENT AND CEO)